Abstract
Purpose :
To characterize and correlate inflammatory T-cell subsets derived from peripheral blood mononucleated cells (PBMC) with clinical parameters of patients with birdshot retinochoroiditis (BSRC).
Methods :
In our pilot study, we examined 11 patients (22 eyes) with BSRC (HLA-A29 postive). Clinical examination and multimodal standard imaging with spectral domain optical coherence tomography, fluorescein angiography (FA), and indocyanine green angiography (ICGA) were performed to classify disease activity. PBMC derived CD4+and CD8+T cellswere analyzed for their naïve, memory, and EMRA status by their CD45RA and CCR7 expression by flow cytometry. The memory compartment was further subdivided into diverse functional subsets regarding the surface expression of 4 chemokine receptors (CCR4, CCR6, CCR10, CXCR3) and the functional profile assessed by intracellular cytokine staining.
Results :
We identified retinal vascular leakage on FA/ICGA as active disease in 10 eyes of 5 patients, while 12 eyes of 6 patients demonstrated no retinal leakage, but altered vascular architecture and retinal thinning as inactive, end-state disease group. The inactive, end-stage disease group revealed a significant accumulation of peripheral CD8+effector memory T cells expressing CD45RA (TEMRA) in blood compared to active disease group. In the active disease group, we found decreased frequencies of Th2 (CCR6-CCR4+CXCR3-) memory CD4+T-cells accompanied by increased Th1 (CCR6-CCR4-CXCR3+) cell frequencies compared to healthy controls and the inactive disease group. Functional assays demonstrated impaired cytokine production of CD4+and CD8+memory T-cells in BSRC patients regardless of their treatment and stage of disease.
Conclusions :
Our preliminary results revealed a Th1/Th2 imbalance in BSRC which may indicate autoimmune processes. High frequencies of CD8+(TEMRA) could be an indicator for a poor prognostic outcome. In addition, decreased cytokine levels in the periphery are probably caused by immunosuppression or exhaustion of the T-cell subsets. Accordingly, we propose to distinguish these cells ex vivo based on the expression of chemokine receptor instead of functional analyses.
These findings offer new insights into the immunological pathophysiology of BSRC disease and may help in defining new biomarkers for monitoring.
This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.